Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1997
09/10/1997EP0793958A2 Process for preparing a composition containing fenofibrate
09/10/1997EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/10/1997EP0793719A2 Rna component of telomerase
09/10/1997EP0793671A1 Phenylsubstituted 4-azasteroid fluoroderivatives
09/10/1997EP0793669A1 L-nucleoside dimer compounds and therapeutic uses
09/10/1997EP0793668A1 Derivatives of carbohydrates and compositions containing them
09/10/1997EP0793667A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
09/10/1997EP0793665A1 Heterocyclic compounds and their preparation and use
09/10/1997EP0793664A1 Morphine and codeine derivatives for use in therapy
09/10/1997EP0793663A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
09/10/1997EP0793662A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
09/10/1997EP0793661A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists
09/10/1997EP0793660A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
09/10/1997EP0793658A1 Oxazole derivatives as antagonists of alpha-1c adrenergic receptors
09/10/1997EP0793657A1 Microbicidal triazolyl derivatives
09/10/1997EP0793656A1 Novel benzyl pyrimidines
09/10/1997EP0793654A1 Antibacterial dibenzimidazole derivatives
09/10/1997EP0793653A1 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
09/10/1997EP0793649A1 18,19-dinor-vitamin d compounds
09/10/1997EP0793648A1 18-nor-vitamin d compounds
09/10/1997EP0793646A1 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
09/10/1997EP0793643A1 Matrix metalloprotease inhibitors
09/10/1997EP0793641A1 Metalloproteinase inhibitors
09/10/1997EP0793507A2 Process for the preparation of a pharmacologically active chemical combination
09/10/1997EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
09/10/1997EP0793499A1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
09/10/1997EP0793498A1 Bicyclic heterocyclic compounds for the treatment of impotence
09/10/1997EP0793496A2 USE OF HALOGENATED $g(b)-CARBOLINES AS MODEL SUBSTANCES TO PRODUCE NEURODEGENERATIVE DISORDERS
09/10/1997EP0793495A1 Freeze-dried ondansetron compositions
09/10/1997EP0793494A1 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
09/10/1997EP0793493A1 Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
09/10/1997EP0793492A1 Treating disorders characterised by excessive cell proliferation with sclareolide
09/10/1997EP0793491A1 Pharmaceutical compositions comprising lycopene
09/10/1997EP0793490A1 Compositions of tocopherol and beta-carotene
09/10/1997EP0793489A1 Compositions for the treatment of skin disorders
09/10/1997EP0793488A1 Increasing fetal hemoglobin levels using carboxylic esters
09/10/1997EP0793487A1 Novel anti-proliferative effects of sodium butyrate
09/10/1997EP0793486A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION
09/10/1997EP0793483A1 Methods of treating lung disease
09/10/1997EP0793476A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
09/10/1997EP0734249A4 Novel and improved aminoglycoside formulation for aerosolization
09/10/1997EP0717627A4 Cosmetic compositions
09/10/1997EP0712403B1 Matrix metalloprotease inhibitors
09/10/1997EP0699073A4 Allogeneic and xenogeneic transplantation
09/10/1997EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
09/10/1997EP0683787B1 4'-o-sulfonyl-anthracycline derivatives
09/10/1997EP0675724B1 Use of dideoxy nucleoside analogues in the treatment of viral infections
09/10/1997EP0674649B1 Antiparasitic agents
09/10/1997EP0664807B1 Quinoxalinedione derivatives as eaa antagonists
09/10/1997EP0664701B1 Taste-masking compositions of ranitidine
09/10/1997EP0644767B1 Veterinary rehydration product
09/10/1997EP0640070B1 Styryl derivatives, their preparation and use as pde-iv inhibitors
09/10/1997EP0625166B1 Sulphated polysaccharides, preparation thereof, pharmaceutical composition and use thereof
09/10/1997EP0625046B1 Pharmaceutical aerosol formulations comprising beclomethasone dipropionate
09/10/1997EP0619304B1 22-oxacholecalciferol derivative and production thereof
09/10/1997EP0586405B1 NOVEL 2H-BENZO[b]PYRANE DERIVATIVES SUBSTITUTED IN THE 4 POSITION BY ARYL OR N-HETEROARYL, PROCESS FOR PRODUCING THEM AND PREPARATIONS CONTAINING THE COMPOUNDS
09/10/1997EP0571520B1 Novel therapeutic use of pycnogenols for the preparation of anti-inflammatory medicaments
09/10/1997EP0566644B1 Method of removing endotoxins
09/10/1997EP0558635B1 Improved matrix metalloprotease inhibitors
09/10/1997EP0544886B1 METHOD OF EXTRACTING SENNOSIDES A, B and A1
09/10/1997CN1159196A Inhibitors of interleukin-1'beta' converting enzyme
09/10/1997CN1159195A Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-YL)-3-oxo-4-aza-5'alpha'-androst-1-ene-17'beta'-carboxamide
09/10/1997CN1159194A Therapeutic compounds
09/10/1997CN1159193A Compounds useful as antiproliferative agents and GARFT inhibitors
09/10/1997CN1159192A Substituted camptothecin derivatives and process for their preparation
09/10/1997CN1159190A Bioactive acetogenins and derivatives
09/10/1997CN1159187A Heterocyclic-and carbocyclic-substituted benzoic acids and synthesis thereof
09/10/1997CN1159183A BIS-(2-haloethyl) aminophenyl substituted distamycin derivatives as antitumor and antiviral agents
09/10/1997CN1159179A Processes for preparation of (E)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide
09/10/1997CN1159162A Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications
09/10/1997CN1159161A Combined hormonal contraception pharmaceutical preparation
09/10/1997CN1159158A Antibacterial oil-in-water emulsions
09/10/1997CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals
09/10/1997CN1158850A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them
09/10/1997CN1158847A New 4-imidazolidinone compound, process for its preparation and pharmaceutical compositions which contain it
09/10/1997CN1158844A Tertiary amines
09/10/1997CN1158732A Aldehyde-olefin scald medicine liquid
09/10/1997CN1158727A Antidiarrheal
09/10/1997CN1158726A Process for making pharmaceutical formulation containing novel steroid esters
09/10/1997CN1158725A Use of 8,9-dehydroestrone as antioxidant
09/10/1997CN1158724A Veterinary antiparasitic lincture contg. avermectin or invermectin
09/10/1997CN1158723A Preparation and application of Ketang'an oral liquid
09/10/1997CN1035821C Prepn. of 4-deoxy-4-epipodophyllotoxin derivatives
09/10/1997CN1035817C Prepn. of triazolyl-substituted tertiary amino compounds and their salts
09/10/1997CN1035803C Soluble hemostyptic fabric
09/10/1997CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals
09/09/1997US5665886 Neurokinin receptor antagonists
09/09/1997US5665883 Treatment of pain, inflammation, migraine, emesis
09/09/1997US5665878 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
09/09/1997US5665874 Cancer related antigen
09/09/1997US5665873 Inhibits reactivation of herpes virus
09/09/1997US5665780 Reversal of multi-drug resistance by tetraarylethylenes
09/09/1997US5665779 Pharmaceutical composition for inhibiting the infection with AIDS virus
09/09/1997US5665778 Ceramides, process for their preparation and their applications in cosmetics and in dermopharmacy
09/09/1997US5665777 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
09/09/1997US5665776 Mixing a pharmaceutically active first ingredient with a second ingredient
09/09/1997US5665774 Treatment of autoimmune diseases
09/09/1997US5665773 Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension
09/09/1997US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
09/09/1997US5665771 Platinum complexes